OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
014830$75200.0059

Unid Co Ltd

Commodity ChemicalsVerified

Unid Co Ltd has a market price of 75,200 KRW and a market cap of 499,247,460,800 KRW, with a price-to-earnings ratio of 7.65 and a price-to-book ratio of 0.46. The company's liquidity position is characterized by a current ratio of 2.18 and a debt-to-equity ratio of 0.23, indicating a moderate level of leverage. The company's liquidity is further supported by 68,929,729,330 KRW in cash and equivalents, although this is offset by 253,046,498,400 KRW in long-term debt, resulting in a net cash position that is negative. In terms of profitability, Unid Co Ltd has a return on equity of 6.03% and a return on assets of 4.28%, which are below the industry median for commodity chemicals. The company's operating margin is 6.57% (calculated as operating income of 87,978,030,730 KRW divided by revenue of 1,338,757,918,770 KRW), which is also below the industry median. The company's gross margin is 17.91% (calculated as gross profit of 239,657,277,310 KRW divided by revenue of 1,338,757,918,770 KRW), which is in line with the industry median. Unid Co Ltd's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's revenue is primarily derived from the sale of chemical products, with no significant diversification into other product lines or markets. The company's exposure to geographic markets is not disclosed, but given the nature of the commodity chemicals industry, it is likely that the company operates in multiple regions. The company's growth trajectory is positive, with a current fiscal year outlook indicating a revenue increase of 5.0% and a next fiscal year outlook of 7.0%. The company's capital expenditure of -84,907,343,000 KRW indicates a reduction in investment, which may be a strategic decision to focus on operational efficiency rather than expansion. The company's free cash flow of 30,855,136,910 KRW suggests that it has sufficient liquidity to fund operations and potentially return value to shareholders. The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk. The key flag of net cash being negative after subtracting total debt suggests that the company may need to manage its debt levels carefully to maintain liquidity. The company's dilution potential is low, with no significant dilution sources identified in the risk assessment. The company's capital structure is relatively stable, with a debt-to-equity ratio of 0.23 and a current ratio of 2.18. Recent events and filings indicate that Unid Co Ltd has a positive outlook from analysts, with a mean price target of 105,285.71 KRW and a median price target of 105,000.00 KRW. The company has received six strong-buy recommendations and four buy recommendations, with no hold recommendations, indicating strong investor confidence. The company's financial performance and strategic direction appear to be aligned with analyst expectations, suggesting that the company is well-positioned to meet its growth targets.

30-day price · 014830(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyUnid Co Ltd
Ticker014830.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Unid Co Ltd is a chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of chemical products.

Classification. Unid Co Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Unid Co Ltd has a market price of 75,200 KRW and a market cap of 499,247,460,800 KRW, with a price-to-earnings ratio of 7.65 and a price-to-book ratio of 0.46. The company's liquidity position is characterized by a current ratio of 2.18 and a debt-to-equity ratio of 0.23, indicating a moderate level of leverage. The company's liquidity is further supported by 68,929,729,330 KRW in cash and equivalents, although this is offset by 253,046,498,400 KRW in long-term debt, resulting in a net cash position that is negative. In terms of profitability, Unid Co Ltd has a return on equity of 6.03% and a return on assets of 4.28%, which are below the industry median for commodity chemicals. The company's operating margin is 6.57% (calculated as operating income of 87,978,030,730 KRW divided by revenue of 1,338,757,918,770 KRW), which is also below the industry median. The company's gross margin is 17.91% (calculated as gross profit of 239,657,277,310 KRW divided by revenue of 1,338,757,918,770 KRW), which is in line with the industry median. Unid Co Ltd's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's revenue is primarily derived from the sale of chemical products, with no significant diversification into other product lines or markets. The company's exposure to geographic markets is not disclosed, but given the nature of the commodity chemicals industry, it is likely that the company operates in multiple regions. The company's growth trajectory is positive, with a current fiscal year outlook indicating a revenue increase of 5.0% and a next fiscal year outlook of 7.0%. The company's capital expenditure of -84,907,343,000 KRW indicates a reduction in investment, which may be a strategic decision to focus on operational efficiency rather than expansion. The company's free cash flow of 30,855,136,910 KRW suggests that it has sufficient liquidity to fund operations and potentially return value to shareholders. The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk. The key flag of net cash being negative after subtracting total debt suggests that the company may need to manage its debt levels carefully to maintain liquidity. The company's dilution potential is low, with no significant dilution sources identified in the risk assessment. The company's capital structure is relatively stable, with a debt-to-equity ratio of 0.23 and a current ratio of 2.18. Recent events and filings indicate that Unid Co Ltd has a positive outlook from analysts, with a mean price target of 105,285.71 KRW and a median price target of 105,000.00 KRW. The company has received six strong-buy recommendations and four buy recommendations, with no hold recommendations, indicating strong investor confidence. The company's financial performance and strategic direction appear to be aligned with analyst expectations, suggesting that the company is well-positioned to meet its growth targets.
Key takeaways
  • Unid Co Ltd has a market price of 75,200 KRW and a market cap of 499,247,460,800 KRW, with a price-to-earnings ratio of 7.65 and a price-to-book ratio of 0.46.
  • The company's liquidity position is characterized by a current ratio of 2.18 and a debt-to-equity ratio of 0.23, indicating a moderate level of leverage.
  • Unid Co Ltd's return on equity of 6.03% and return on assets of 4.28% are below the industry median for commodity chemicals.
  • The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification.
  • The company's growth trajectory is positive, with a current fiscal year outlook indicating a revenue increase of 5.0% and a next fiscal year outlook of 7.0%.
  • Unid Co Ltd has a positive outlook from analysts, with a mean price target of 105,285.71 KRW and a median price target of 105,000.00 KRW.
  • # RATIONALES
  • {
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$1.34T
Gross profit$239.66B
Operating income$87.98B
Net income$65.26B
R&D
SG&A
D&A
SBC
Operating cash flow$89.48B
CapEx-$84.91B
Free cash flow$30.86B
Total assets$1.52T
Total liabilities$441.90B
Total equity$1.08T
Cash & equivalents$68.93B
Long-term debt$253.05B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.34T$87.98B$65.26B$30.86B
FY-1$1.11T$95.45B$76.23B-$3.57B
FY-2$1.13T$28.76B$16.26B-$52.76B
FY-3$1.40T$145.00B$124.27B$77.21B
FY-4$877.11B$148.86B$182.55B$143.28B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$1.52T$1.08T$68.93B
FY-1$1.36T$1.01T$71.15B
FY-2$1.26T$903.11B$146.03B
FY-3$1.49T$901.55B$135.44B
FY-4$1.35T$995.57B$152.30B
PeriodOCFCapExFCFSBC
FY0$89.48B-$84.91B$30.86B
FY-1$116.80B-$123.03B-$3.57B
FY-2$334.71B-$104.51B-$52.76B
FY-3-$128.09B-$84.04B$77.21B
FY-4$121.77B-$65.13B$143.28B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$384.41B$25.50B$24.87B$25.53B
FQ-1$346.33B$7.58B$2.35B$335.7M
FQ-2$328.98B$18.85B$16.83B$1.35B
FQ-3$340.94B$32.82B$23.78B$23.56B
FQ-4$322.51B$28.73B$22.30B$17.56B
FQ-5$275.51B$12.45B$7.59B-$13.38B
FQ-6$289.78B$20.46B$19.84B$4.50B
FQ-7$291.64B$35.04B$27.15B-$1.75B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$1.71T$1.16T$100.46B
FQ-1$1.52T$1.08T$68.93B
FQ-2$1.43T$1.05T$45.71B
FQ-3$1.34T$1.02T$62.54B
FQ-4$1.38T$1.02T$61.69B
FQ-5$1.36T$1.01T$71.15B
FQ-6$1.32T$979.09B$80.27B
FQ-7$1.32T$963.42B$52.84B
PeriodOCFCapExFCFSBC
FQ0-$34.55B-$15.85B$25.53B
FQ-1$89.48B-$84.91B$335.7M
FQ-2$41.42B-$66.91B$1.35B
FQ-3$48.14B-$35.94B$23.56B
FQ-4$38.41B-$20.19B$17.56B
FQ-5$116.80B-$123.03B-$13.38B
FQ-6$70.29B-$87.82B$4.50B
FQ-7$16.93B-$58.80B-$1.75B
Valuation
Market price$75200.00
Market cap$499.25B
Enterprise value$683.36B
P/E7.7
Reported non-GAAP P/E
EV/Revenue0.5
EV/Op income7.8
EV/OCF7.6
P/B0.5
P/Tangible book0.5
Tangible book$1.08T
Net cash-$184.12B
Current ratio2.2
Debt/Equity0.2
ROA4.3%
ROE6.0%
Cash conversion1.4%
CapEx/Revenue-6.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric014830Activity
Op margin6.6%0.4% medp25 -8.0% · p75 16.0%above median
Net margin4.9%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin17.9%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-6.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity23.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target105,285.71 KRW
Median price target105,000.00 KRW
High price target117,000.00 KRW
Low price target93,000.00 KRW
Mean recommendation1.40 (1=strong buy, 5=strong sell)
Strong-buy count6.00
Buy count4.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate12,997.20 KRW
Last actual EPS9,736.00 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 01:43 UTCJob: d9495f3a